CIANPOD DRY SYP
Each 5 ml Reconstituted Suspension Contains: Cefpodoxime Proxetil IP Eq. to Cefpodoxime 100 mg Excipients...q.s
| Composition | Each 5 ml Reconstituted Suspension Contains: Cefpodoxime Proxetil IP Eq. to Cefpodoxime 100 mg Excipients...q.s |
| Packing | outer carton with plastic bottle - 30 ML |
| MRP | ₹159 |
Product Overview
CIANPOD DRY SYP is a high-potency pediatric oral antibiotic suspension containing 100mg of Cefpodoxime per 5ml dose. It provides an effective clinical solution for managing moderate to severe bacterial infections in older children and adolescents. Positioned as a core antibiotic requirement, this formulation offers excellent commercial scope for pharmaceutical franchise partners.
Indications
This high-strength pediatric suspension is indicated for treating various acute bacterial infections:
- Acute Maxillary Sinusitis: Infections affecting the paranasal sinuses.
- Tonsillopharyngitis: Severe recurrent throat infections caused by susceptible pathogens.
- Acute Bronchitis and Pneumonia: Upper and lower respiratory tract infections.
- Skin and Soft Tissue Infections: Uncomplicated superficial skin infections.
Dosage & Administration
Administer orally. The standard pediatric dose is calculated based on body weight, typically utilizing 10 mg/kg/day split into two divided doses every 12 hours, up to a maximum adult equivalent dose. Reconstitute the powder with boiled and cooled water up to the marked line on the container before the initial dose.
Adverse Effects
Side effects are generally mild and self-limiting, including:
- Gastrointestinal disturbances such as diarrhea or vomiting
- Abdominal pain or flatulence
- Temporary skin rashes or hives
- Oral thrush or fungal overgrowth
View Complete Medical Information
Contraindications
Contraindicated in patients with known severe allergies or anaphylactic history related to cephalosporins or beta-lactam antibiotics. Do not use in neonates with absolute renal insufficiency.
Warnings & Precautions
Prolonged usage can promote the overgrowth of non-susceptible organisms. Exercise caution when administering to patients with moderate renal impairment, and monitor bowel habits closely due to the risk of pseudomembranous colitis.
Drug Interactions
Oral bioavailability is compromised if administered concurrently with antacids, buffering agents, or anticholinergic drugs that alter gastric pH. Nephrotoxic drugs like loop diuretics should be monitored if co-prescribed.
Storage Instructions
Store the dry powder pack below 25°C, away from moisture. Keep the reconstituted liquid suspension under refrigeration between 2°C and 8°C, ensuring usage is completed within 10 to 14 days maximum.
Product image not available
Request This Product
- WHO-GMP Certified Formulations
- Monopoly Rights Available
- Get bulk pricing & MOQ
+91 9689237122 · replies within hours
Related Products
More products in the ANTIBIOTIC therapeutic category
I CEF 1.5 INJ
Composition:Each vial contains: Ceftriaxone 1000mg Sulbactam 500mg
VIAL WITH SWFI AND CARTON - 1 VialPack Style: Vial
I TRANS 4.5 INJ
Composition:Each vial contains: Piperacillin 4 gm Tazobactam 0.5 gm
VIAL WITH SWFI - 1 VialPack Style: Vial
CIANCLAV 625 TAB [NEW]
Each film coated tablet contains : Amoxicillin Trihydrate IP Eq. to Amoxicillin 500mg Potassium Clavulanate IP (As Potasssium Clavulanate Diluted IP) Eq. to Clavulanic Acid 125mg
ALU ALU IN MONOCARTON & SHRINK - 10*1*10
Interested in this product?
Contact our team to discuss PCD franchise, bulk orders, or contract manufacturing for your market.